Duke University - Recruiting 18 years to 65 years. - An Open Label, Flexible Dose Study of Very Low Doses of Naltrexone-Buprenorphine Transfer to Extend-Release Naltrexone (VIVITROLr) in Opioid Addiction.
very low dose naltrexone; extended release naltrexone; buprenorphine/naloxone
Orexo AB - Recruiting 18 years to 65 years. - Induction, STabilization, Adherence and Retention Trial (ISTART) - A Randomized Non-inferiority Multicenter Study to Assess Early Treatment Efficacy of OX219 Versus SUBOXONE Film and to Explore Switching Between Treatments.
Orexo AB - Recruiting 18 years to 65 years. - A Multi-center, Open-label, 24-week, Follow-up Study to Assess Safety, Efficacy and Treatment Adherence for Maintenance Treatment of Opioid Dependence With OX219.
University of California, San Francisco - Recruiting 18 years or older. - The Effects of Intranasal Oxytocin on Social Cognition and Social Approach Behaviors in Opioid-dependent Patients Receiving Methadone Treatment.
New York State Psychiatric Institute - Recruiting 18 years to 60 years. - Long-acting Injectable Naltrexone Induction: A Randomized Trial of Outpatient Opioid Detoxification With Naltrexone vs. Buprenorphine.